Enzolytics Inc (ENZC)

[falon]

You may be right.

Why change from 14287 to 17092?

And what is quite interesting or should I say odd it is not list on their website.

This is definitely new:

Brief Summary

The purpose of this study is to learn about the safety and tolerability of different doses of REGN17092 administered with a needle either under the skin (called "subcutaneous") or into a vein (called an "infusion") in healthy participants. This is the first time that REGN17092 will be given to people.

Other aims are to assess:

How much of the study drug is in the blood at different times
Whether the body makes its own antibodies against the study drug (which could make the drug less effective or lead to side effects)